As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to apply to a newly established review board for approval. Once its treatment is rubber-stamped, the…
We were taught to climb the corporate ladder and avoid lateral moves, but we’re increasingly playing by a new set of rules that rewards a more intentional strategy
One simple shift — from building a booth to creating a real emotional moment — turned passing foot traffic into meaningful conversations and lasting brand connections.